Marcelo Langer Wroclawski

Marcelo Langer Wroclawski

Auto-generated profile, based on publicly available information

Marcelo Langer Wroclawski

Hospital Israelita Albert Einstein, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2021 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
DCDaniele Castellani
Daniele Castellani
MWMarcelo Langer Wroclawski
Marcelo Langer Wroclawski
GPGiacomo Maria Pirola
Giacomo Maria Pirola
Vineet GauharVineet Gauhar
Vineet Gauhar
EREmanuele Rubilotta
Emanuele Rubilotta
Jeremy Yuen Chun TeohJeremy Yuen Chun Teoh
Jeremy Yuen Chun Teoh

14 June 2022 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
ÁBÁlan Roger Gomes Barbosa
Álan Roger Gomes Barbosa
LTLucas Seiti Takemura
Lucas Seiti Takemura
BABreno Santos Amaral
Breno Santos Amaral
MWMarcelo Langer Wroclawski
Marcelo Langer Wroclawski
WAWladimir Alfer
Wladimir Alfer
ACArie Carneiro
Arie Carneiro
Objective To describe and compare the number of surgeries, mortality rate, length of hospital stay, and costs of transurethral resection of the prostate and open prostatectomy for the treatment of benign prostatic hyperplasia, between 2008 and 2018, in the Public Health System in São Paulo, Brazil. Methods Ecological and retrospective study using data from the informatics department of the Brazilian Public Health System database. Procedure codes were “open prostatectomy” and “transurethral resection of the prostate.” The outcomes analyzed were

17 September 2025 in BMC Urology
Verified
Journal Article
Open access
PDF file
MTMax Traeger
Max Traeger
TWTabea Walther
Tabea Walther
Jeremy Yuen Chun TeohJeremy Yuen Chun Teoh
Jeremy Yuen Chun Teoh
MWMarcelo Langer Wroclawski
Marcelo Langer Wroclawski
THThomas R.W. Herrmann
Thomas R.W. Herrmann
DSDominik Schoeb
Dominik Schoeb
Background: Up to 50% of patients with benign prostate hyperplasia (BPH) face post-operative complications after transurethral prostate Surgery. This includes nearly 15% of patients suffering from prolonged post-operative pelvic pain (pPPP) consisting of dysuria and prostatodynia for sometimes several months post-surgery. This study elucidates and proposes a definition of the multi-dimensional nature of prolonged post-operative pelvic pain (pPPP) after transurethral prostate surgery by providing real-world data on therapeutic options and their efficacy. Methods: German and international urologic practitioners participated in an online-survey after invitation via social media accounts and newsletters. The survey included questions on the amount of expertise, the therapeutic regimens for prolonged post-operative pelvic pain (pPPP) and the expected therapy outcome. Participation was voluntary and uncompensated. Chi-Square tests and Student’s t-tests were used for descriptive statistics. Results: 67 German urologists participated in a 9-question online Survey. 94,0% treated patients with lower urinary tract symptoms and 85,1% disclosed their therapeutic regime for prolonged post-operative pelvic pain (pPPP). The most common treatments included anti-inflammatory medication (69,6%), anti-cholinergics (53,6%), alpha-blockers (51,8%) and pelvic physiotherapy (50,0%). Over half of the patients responded to the therapeutic approach, but only 5,4% of urologists anticipated full pain relief after one year. These findings are closely aligned with a recent international survey (n=230). Notably, German urologists more frequently prescribed anti-cholinergics (53,6% vs. 28,7%, p = 0,0004), herbal remedies like saw palmetto (25,0% vs. 6,5%, p < 0,0001) and non-pharmacological therapies (82,1% vs. 49,1%, p < 0,0001), but less anti-inflammatory drugs (69,6% vs. 88,7%, p = 0,0003), gabapentin/pregabalin (8,9% vs. 42,2%, p < 0,0001) and opioids (0% vs 5,7%, p = 0,0221). Based on these results a structured definition and therapy plan for prolonged post-operative pelvic pain (pPPP) is proposed. Conclusion: Prolonged post-operative pelvic pain (pPPP) is a common challenge for urologists. Despite various therapeutic options, treatment outcomes and practitioner confidence remain suboptimal. Further research and attention to prolonged post-operative pelvic pain (pPPP) are essential to develop evidence-based guidelines for effective patient management and prevention of chronic pain syndromes.